Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Medtronic plc MDT has secured FDA approval for the Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The clearance provides U.S. surgeons and the health system with a ...

Medtronic’s Hugo robotic-assisted surgery system receives US FDA clearance for urologic surgical procedures: Galway, Ireland ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

The Business Research Company's Urology Robotic Surgery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores Market ...

Fred Moll, the cofounder of $200 billion Intuitive Surgical, has invested in some 15 companies building robots that could ...

A single-institution study found no significant increase in the risk for complications or readmissions between patients who underwent robotic urologic surgery before and during the COVID-19 pandemic.

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...